Survival after Sublobar Resection for Early-Stage Lung Cancer: Methodological Obstacles in Comparing the Efficacy to Lobectomy  Emanuela Taioli, MD, PhD,

Slides:



Advertisements
Similar presentations
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Advertisements

Epidemiology of Environmental Exposure and Malignant Mesothelioma
Thomas J. Birdas, MD, Richard P. M
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer  Raja Flores, MD, Thomas Bauer, MD, Ralph.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Epidemiology of Environmental Exposure and Malignant Mesothelioma
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules  Nasser K. Altorki, MD, Rowena Yip, MPH, Takaomi Hanaoka,
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma  Emanuela Taioli, MD, PhD, Andrea S. Wolf,
Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 
Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H
Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review.
Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data.
The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer  Boris Sepesi, MD, Kathryn A. Gold, MD,
Emanuela Taioli, MD, PhD, Andrea S
Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Andrea S. Wolf, MD, MPH, Scott J
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430  Thomas E.
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology,
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Thomas J. Birdas, MD, Richard P. M
Andrea S. Wolf, MD, William G. Richards, PhD, Michael T
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis  Elizabeth A. David, MD, Megan E.
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition  Sai-Hong.
Outcomes for Thoracoscopy Versus Thoracotomy Not Just Technique Dependent: A Study of 9,787 Patients  Andrea Wolf, MD, MPH, Bian Liu, PhD, Emanuele Leoncini,
A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer  Christopher.
A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596):
Treatment Outcomes in Stage I Lung Cancer
Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Thoracoscopic Lobectomy Produces Long-Term Survival Similar to That with Open Lobectomy in Cases of Non–Small Cell Lung Carcinoma: A Propensity-Matched.
Onkar V. Khullar, MD, Yuan Liu, PhD, Theresa Gillespie, PhD, Kristin A
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed  Emanuela Taioli, MD, PhD, Raja Flores, MD 
A Primer on Health Economic Evaluations in Thoracic Oncology
Role of Postoperative Radiotherapy in Nonlocalized Thymoma
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.
It’s All in the “Swerve of the Curve”
Immune-Modulating Vaccines in Non-small Cell Lung Cancer
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base  Susan E. Combs, MA, Jacquelyn.
Genetic Changes in Squamous Cell Lung Cancer: A Review
Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm  Brendon M. Stiles, MD, Jialin Mao, MD,
European Lung Cancer Conference (ELCC) 2016 Organisation
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
A Review of First-Line Treatment for Small-cell Lung Cancer
Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006  Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Robert Comis, MD, The Passing of a “Lung Man”
Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues”  Boris Sepesi,
Presentation transcript:

Survival after Sublobar Resection for Early-Stage Lung Cancer: Methodological Obstacles in Comparing the Efficacy to Lobectomy  Emanuela Taioli, MD, PhD, Rowena Yip, MPH, Ingram Olkin, PhD, Andrea Wolf, MD, MPH, Daniel Nicastri, MD, Claudia Henschke, MD, PhD, David Yankelevitz, MD, Harvey Pass, MD, Raja M. Flores, MD  Journal of Thoracic Oncology  Volume 11, Issue 3, Pages 400-406 (March 2016) DOI: 10.1016/j.jtho.2015.10.022 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Absolute difference in 5-year survival between lobectomy versus sublobectomy for stage I lung cancer from 1994 to 2014 (absolute numbers are reported in Table 1 under the 5-year survival column). Note: red dots denote studies on stage IA lung cancers; square dots denote the two propensity matched studies; the orange horizontal line marks the difference in survival reported by the only randomized clinical trial,1 for comparative purposes (stage was determined using radiography in the randomized trial). Journal of Thoracic Oncology 2016 11, 400-406DOI: (10.1016/j.jtho.2015.10.022) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions